New Key Statistics Module, Z-Score and F-Score
OTCPK:BOVNF Key Ratios
| Market Cap $ M | 268.98 |
| Enterprise Value $ M | 170.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 4.94 |
| Price/Book | 2.59 |
| Price/Sales | 54.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4.00 |
| EPS (TTM) $ | -0.55 |
| Beneish M-Score | -3.39 |
| 10-y EBITDA Growth Rate % | 15.00 |
| 5-y EBITDA Growth Rate % | 25.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.62 |
| EV-to-EBITDA | -4.85 |
| PEG | -- |
| Shares Outstanding M | 65.80 |
| Net Margin (%) | -728.10 |
| Operating Margin % | -817.52 |
| Pre-tax Margin (%) | -727.60 |
| Quick Ratio | 12.18 |
| Current Ratio | 12.30 |
| ROA % (ttm) | -27.35 |
| ROE % (ttm) | -29.40 |
| ROIC % (ttm) | -132.87 |
| Dividend Yield % | -- |
| Altman Z-Score | 16.83 |
BOVNF Number of Guru Trades
BOVNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BOVNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BOVNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioInvent International AB Insider Transactions
No Available Data
News about OTCPK:BOVNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers